Abbvie Inc (NYSE:ABBV)
142.55 Delayed Data As of Aug 16 | ![]() Today’s Change | 105.56 Today|||52-Week Range 175.91 | +5.28% Year-to-Date |
Latest ABBV News | Press Releases
Top 5 2nd Quarter Trades of Brick & Kyle, Associates Aug 16 / GuruFocus News - Paid Partner Content | Principal Street Partners, LLC Buys 1, Sells 4 in 2nd Quarter Aug 15 / GuruFocus News - Paid Partner Content |
Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA Aug 16 / Zacks.com - Paid Partner Content | FIRST TRUST ADVISORS LP Buys 4, Sells 1 in 2nd Quarter Aug 12 / GuruFocus News - Paid Partner Content |
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It Aug 16 / Zacks.com - Paid Partner Content | FRONT BARNETT ASSOCIATES LLC Buys 1, Sells 4 in 2nd Quarter Aug 12 / GuruFocus News - Paid Partner Content |
5 Income Stocks to Turn to When Times Are Tough Aug 16 / StockNews.com - Paid Partner Content | Want Passive Income? Try These 3 Dividend Stocks Aug 11 / StockNews.com - Paid Partner Content |
3 Blue-Chip Stocks That'll Help Your Portfolio Survive Aug 16 / StockNews.com - Paid Partner Content | 4 "Strong Buy" Stocks for a Fear-Driven Market Aug 10 / StockNews.com - Paid Partner Content |
Today’s Trading
Previous close | 142.29 |
Today’s open | 142.30 |
Day’s range | 142.08 - 143.87 |
Volume | 3,852,310 |
Average volume (3 months) | 6,771,438 |
Market cap | $252.1B |
Data as of 4:00pm ET, 08/16/2022
Growth & Valuation
Earnings growth (last year) | +137.07% |
Earnings growth (this year) | +9.01% |
Earnings growth (next 5 years) | -2.24% |
Revenue growth (last year) | +22.69% |
P/E ratio | 20.2 |
Price/Sales | 4.28 |
Price/Book | 16.37 |
Competitors
Today’s change | Today’s % change | |
---|---|---|
MRKMerck | -0.03 | -0.03% |
PFEPfizer | +0.13 | +0.26% |
AZNAstraZeneca | -0.07 | -0.10% |
LLYEli Lilly and Co | -3.43 | -1.09% |
Data as of 4:00pm ET, 08/16/2022
Financials
Next reporting date | November 4, 2022 |
EPS forecast (this quarter) | $3.60 |
Annual revenue (last year) | $56.2B |
Annual profit (last year) | $11.5B |
Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
